Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

NKX2-5 – Tetralogy of Fallot

NKX2-5 encodes a cardiac homeobox transcription factor essential for heart development. A case–control study of 150 Egyptian children with congenital heart disease, including tetralogy of Fallot, found the NKX2-5 rs2277923 CT genotype in 58% of cases versus 36% of controls and the rs28936670 AG genotype in 82% of cases, suggesting a modest risk effect (PMID:30834692). However, sequencing of fresh cardiac tissues from 38 unrelated non-syndromic tetralogy of Fallot patients revealed no somatic NKX2-5 mutations, indicating that pathogenic somatic variants are uncommon in this cohort (PMID:21519287). A heterozygous missense change c.73C>T (p.Arg25Cys) was identified in a single tetralogy of Fallot proband but also found in healthy relatives and controls, challenging its role as a disease-causing allele (PMID:17891434). To date, no pathogenic germline NKX2-5 variants have been shown to segregate with tetralogy of Fallot in families, and the evidence for causality remains limited.

Functional studies support NKX2-5 haploinsufficiency as a mechanism for cardiac malformations. Nkx2-5 knockout mice exhibit embryonic lethality, ventricular and conduction system hypoplasia, and altered expression of downstream targets such as atrial natriuretic factor (PMID:11572777). Yeast-based transactivation assays of homeodomain mutants demonstrate loss-of-function and dosage sensitivity for alleles associated with septal defects (PMID:15917268). Although these data confirm NKX2-5’s critical role in cardiogenesis, direct experimental modeling of tetralogy of Fallot remains lacking. Additional case series and mechanistic insights exceed the ClinGen scoring cap. Key take-home: Common NKX2-5 variants show association with risk for tetralogy of Fallot, but definitive pathogenic alleles and familial segregation are not yet established, underscoring the need for comprehensive genetic and functional studies.

References

  • Molecular genetics & genomic medicine • 2019 • Association of NKX2-5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children. PMID:30834692
  • Pathology • 2011 • Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot. PMID:21519287
  • Pediatric cardiology • 2008 • The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: mutation or polymorphism? PMID:17891434
  • Cell • 2001 • A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. PMID:11572777
  • Human molecular genetics • 2005 • Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. PMID:15917268

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

One small case–control association (150 cases including TOF) with NKX2-5 SNP risk alleles and no confirmed pathogenic germline mutations or familial segregation; negative somatic screen in 38 TOF tissues

Genetic Evidence

Limited

Association based on two common NKX2-5 variants (rs2277923, rs28936670) in sporadic CHD including tetralogy of Fallot without pathogenic alleles or segregation (PMID:30834692)

Functional Evidence

Moderate

Nkx2-5 haploinsufficiency in murine models recapitulates cardiac hypoplasia and conduction defects; yeast assays of homeodomain mutants show loss-of-function relevant to septal defects (PMID:11572777; PMID:15917268)